Overview
- The Energy Department offered a conditional $263 million loan to help SHINE finish its Chrysalis facility in Janesville, with funding contingent on technical, legal, environmental, and financial approvals.
- The plant plans to produce molybdenum-99, which decays into technetium-99m used in about 40,000 medical scans a day in the U.S., replacing supplies now imported from Europe, South Africa, and Australia.
- SHINE and federal officials say the site is designed to supply up to 20 million diagnostic tests a year and to become both the largest Mo-99 facility and the largest commercial use of fusion.
- SHINE reports construction is roughly 75% to 80% complete with equipment installation ahead, and the company says it expects initial production in 18 to 24 months and full scale in three to four years.
- Local leaders and the company project about 200 construction jobs and 150 permanent roles, and the facility is also planned to make other medical isotopes such as iodine-131 and xenon-133.